Flagship Ventures Fund IV, L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Flagship Ventures Fund IV, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Flagship Ventures Fund IV, L.P.. Flagship Ventures Fund IV, L.P. is a 10% Owner in Eleven Biotherapeutics, Inc. ($EBIO) and a 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and a 10% Owner in Editas Medicine, Inc. ($EDIT).
Address: 1 MEMORIAL DRIVE CAMBRIDGE 02142 MA
Companies in which Flagship Ventures Fund IV, L.P. is an Insider
Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund IV, L.P.: 10% Owner
Holdings: 2,764,256 shares
Current Value: $51,304,591
Latest Transaction: Aug 15 2016
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sesen Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Flagship Ventures Fund IV, L.P.: 10% Owner
Holdings: 668,912 shares
Current Value: $1,565,254
Latest Transaction: Sep 26 2016
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Flagship Ventures Fund IV, L.P.: 10% Owner
Holdings: 2,378,663 shares
Current Value: $25,975,000
Latest Transaction: Aug 21 2017
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Flagship Ventures Fund IV, L.P.
Sentiment: All, EDIT, SESN, SYRS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2017 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 54,293 | 0 | 0 | 54.3 K to 0 (-100.00 %) |
| Aug 21 2017 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 306,222 | 0 | 612,442 | 918.7 K to 612.4 K (-33.33 %) |
| Aug 21 2017 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 1,295,997 | 0 | 2,378,663 | 3.7 M to 2.4 M (-35.27 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.10 | 10,293 | 31,908 | 106,787 | 117.1 K to 106.8 K (-8.79 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.10 | 41,178 | 127,652 | 426,885 | 468.1 K to 426.9 K (-8.80 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.16 | 3,118 | 9,853 | 117,080 | 120.2 K to 117.1 K (-2.59 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.16 | 12,482 | 39,443 | 468,063 | 480.5 K to 468.1 K (-2.60 %) |
View all Flagship Ventures Fund IV, L.P. insider transactions.